Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PROPRANOLOL HYDROCHLORIDE USP, with a corresponding US DMF Number 39782.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 31, 2025, and payment made on January 07, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II